TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977
TCL Archive AACR settles dispute with Toronto Convention Center and hotels over cancellation of 2003 annual meeting. Travelers Insurance covered AACR’s claim. April 15, 2005
TCL Archive Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development March 15, 1991
TCL Archive In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30 September 20, 1974